Tag: Biotech Stock News
Genprex (GNPX) Stock: Reprogramming The Course Of Cancer
THE INTRO
GENPREX, INC. (NASDAQ: GNPX) which is honoring its mission to REPROGRAMMING THE COURSE OF CANCER, is...
Hemispherx Biopharma (HEB) Stock Is Well Positioned For A Strong Future
Hemispherx Biopharma (NYSEAMERICAN: HEB), a research and development biotechnology company, is grabbing the attention of the investing community, and for good reason....
ArQule (ARQL) Stock: Rocketing On Clinical Data
ArQule, Inc. (NASDAQ: ARQL) is having a great start to the trading session this morning, and for good reason. The company announced preliminary results...
La Jolla Pharmaceutical (LJPC) Stock: Continuing Its Run For The Top
La Jolla Pharmaceutical Company (NASDAQ: LJPC) is climbing in the market yet again today, following up on the incredible gains that the stock saw...
ReWalk Robotics (RWLK) Stock: Flying On Funding News
ReWalk Robotics Ltd (NASDAQ: RWLK) is flying early on in the trading session after the company announced funding news. According to a press release,...
Actinium Pharmaceuticals (ATNM) Stock: Climbing On New Pivotal Data
Actinium Pharmaceuticals Inc (NYSEAMERICAN: ATNM) is headed up early on in the trading session with gains of more than 6% just after the opening...
Precipio (PRPO) Stock: Up On Exclusive Manufacturing Agreement
Precipio Inc (NASDAQ: PRPO) is making a run for the top in the market this morning after announcing that it has entered into an...
Proteostasis Therapeutics (PTI) Stock: Up On Orphan Drug Designation
Proteostasis Therapeutics Inc (NASDAQ: PTI) is grabbing the attention of investors with premarket gains of more than 20%. The gains come after the company...
Genocea Biosciences (GNCA) Stock: Cancer Vaccine Data Leads To Gains
Genocea Biosciences Inc (NASDAQ: GNCA) is grabbing the attention of investors this morning after announcing data from an early-stage clinical trial assessing a cancer...
MannKind (MNKD) Stock: Gains On Brazil Approval
MannKind Corporation (NASDAQ: MNKD) is catching the attention of investors this morning after announcing the approval of Affrezza in Brazil. As a result of...
MagneGas: A Zombie Fest Bursting With Hype, Horrifying Financials, Downside Risk
MagneGas Corporation's (MNGA) outlandish hype and financials remind us of those lurching, snarling, misunderstood zombies populating the horror film “Night of the Living Dead.”
At...
Reviews
TradeMiner Review: Is It Worth Your While?
There are tons of trading tools out there, but none of them are quite like TradeMiner. The software doesn’t look at your...
